Coya Therapeutics (COYA) Cash from Investing Activities (2022 - 2026)

Coya Therapeutics (COYA) has 5 years of Cash from Investing Activities data on file, last reported at -$885000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$885000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (changed N/A YoY), and the FY2025 full-year result was -$1.2 million, down 4558.41% from the prior year.
• Cash from Investing Activities declined to -$885000.0 in Q1 2026, from -$648606.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$25000.0 in Q1 2024 to a low of -$885000.0 in Q1 2026.
• A 5-year average of -$428358.4 and a median of -$390000.0 in 2022 frame the typical range for Cash from Investing Activities.
• Peak annual rise in Cash from Investing Activities reached 50.47% in 2023, while the deepest fall reached 50.47% in 2023.
• Tracing COYA's Cash from Investing Activities over 5 years: stood at -$390000.0 in 2022, then jumped by 50.47% to -$193186.0 in 2023, then jumped by 87.06% to -$25000.0 in 2024, then tumbled by 2494.42% to -$648606.0 in 2025, then sank by 36.45% to -$885000.0 in 2026.
• Business Quant data shows COYA's Cash from Investing Activities at -$885000.0 in Q1 2026, -$648606.0 in Q4 2025, and -$25000.0 in Q1 2024.